Morgan Stanley Raises KOSPI Target to 5,200 on Strong Earnings and Reform Momentum

Morgan Stanley has raised its end-2026 target for South Korea’s benchmark stock index, the KOSPI, citing robust earnings momentum and ongoing structural reforms that continue to support further upside despite the market’s sharp rally. In a recent research note, the U.S. investment bank increased its end-2026 KOSPI target to 5,200 from a previous estimate of 4,500, signaling growing confidence in the outlook for South Korean equities.

The bank noted that it is now leaning closer to its bull-case scenario of 6,000 for the KOSPI, compared with a bear-case projection of 4,200. In addition, Morgan Stanley set a new three- to six-month trading range of 4,600 to 5,800, reflecting expectations of a stronger first half of 2026 relative to the second half. This outlook underscores the bank’s view that the recent rally still has room to run, even as volatility may emerge in the near term.

According to the analysts, South Korea remains one of the best-positioned equity markets in Asia. Key drivers include powerful super-cycles in technology and industrials, improving earnings revision trends, and continued government-led corporate governance and capital market reforms. These factors are helping to enhance market transparency, shareholder returns, and overall investor confidence.

Morgan Stanley expects earnings growth to be front-loaded this year, supported by a recovery in the semiconductor sector and sustained demand linked to artificial intelligence and energy transition themes. While the KOSPI is approaching the psychologically important 5,000 level after a near-vertical rise since late 2025, the bank believes any near-term pullbacks are likely to be shallow and temporary.

The analysts also highlighted that geopolitical risks have historically caused only short-lived volatility for Korean equities, rather than long-term damage. In terms of sector strategy, Morgan Stanley reiterated its overweight stance on information technology, industrials, and autos, while remaining constructive on financials, particularly securities firms that stand to benefit from stronger capital markets activity.